MSA Team Works Toward Publications

March 16, 2020

MSA has submitted three manuscripts in high impact journals that report the results of pre-clinical experiments evaluating the pharmacokinetics (nasal absorption), pharmacodynamics (efficacy), and safety in support of Bryn Pharma’s goal to bring a cost-effective intranasal delivery system for patients with anaphylaxis to market.

MSA authors include Principals Dr. Kenneth Dretchen Ph.D., Zack Mesa, and Michael Mesa, along with MSA associate Matt Robben Ph.D.

MSA News

MSA Intern Graduates

Mesa Science Associates is pleased to announce that Peyton Coady, a former intern at MSA will be graduating from James…

Read More

Progress During the Pandemic

August 31, 2020 – Our surviving the Covid-19 experience has been an example of what having a great team can…

Read More

MSA and COVID-19

Frederick, MD July 17, 2020 – MSA has decided to delay the full-time return to our Frederick offices indefinitely.  Unfortunately,…

Read More